Literature DB >> 3183969

Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study.

J I Choca1, R D Green, H K Proudfit.   

Abstract

Tissue autoradiography was used to examine the distribution of A1 and A2 adenosine receptors in the rat spinal cord. The distribution of binding sites for the A1 selective agonist, N6-[3H]-[(R)-1-methyl-2-phenylethyl]adenosine (R-[3H]PIA), was similar to the distribution of binding sites for [3H]-5'-N-ethylcarboxamide adenosine [( 3H]NECA), an agonist that binds to A1 and A2 receptors with nearly equal affinities. Binding site densities were highest in the substantia gelatinosa, followed by lamina 10; the remainder of the spinal cord displayed uniformly low levels of binding sites. In each of these three areas, [3H]NECA bound to more sites than R-[3H]PIA. When the A1-selective agonist, N6-(cyclopentyl)adenosine, was used to block [3H]NECA binding to A1 receptors, the autoradiograms demonstrated a band of A2 receptor density which tended to be localized in the ventral portion of the substantia gelatinosa. Unilateral dorsal rhizotomy, hemitransection and complete transection of the spinal cord failed to alter the [3H]NECA or R-[3H]PIA binding in the substantia gelatinosa. In contrast, unilateral microinjections of kainic acid into the dorsal horn decreased [3H]NECA and R-[3H]PIA binding at the level of the injections by 42 and 37%, respectively. In some areas, kainic acid injection eliminated all R-[3H]PIA and [3H]NECA binding in the substantia gelatinosa. It is therefore concluded that spinal cord A1 and A2 adenosine receptors in the substantia gelatinosa are located predominantly on intrinsic neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183969

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.

Authors:  N K Katz; J M Ryals; D E Wright
Journal:  Neuroscience       Date:  2014-11-08       Impact factor: 3.590

2.  Adenosine receptor agonists modulate visceral hyperalgesia in the rat.

Authors:  Chong-Il Sohn; Hyo Jin Park; G F Gebhart
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

Review 3.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 4.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

Review 5.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

6.  Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices.

Authors:  M R Vasko; H Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

7.  Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat.

Authors:  Syuichiro Yamamoto; Osamu Nakanishi; Tomohiro Matsui; Noriyuki Shinohara; Hiroyuki Kinoshita; Clinton Lambert; Toshizo Ishikawa
Journal:  Cell Mol Neurobiol       Date:  2003-04       Impact factor: 5.046

8.  The interaction of intrathecal neostigmine and N-cyclohexyladenosine on anti-allodynic effects in rats with a nerve ligation injury.

Authors:  Dae Kee Choi; Seong Soo Choi; Jai Hyun Hwang
Journal:  Korean J Anesthesiol       Date:  2010-07-21

9.  The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat.

Authors:  A J Reeve; A H Dickenson
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Interaction between intrathecal gabapentin and adenosine in the formalin test of rats.

Authors:  Myung Ha Yoon; Jeong Il Choi; Heon Chang Park; Hong Beom Bae
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.